Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-206' Or cancer = '' Total: 43 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-206 bladder cancer down MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC.
hsa-mir-206 breast cancer down miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.
hsa-mir-206 breast cancer up Expression of miRNA-206 and miRNA-145 in breast cancer and correlation with prognosis.
hsa-mir-206 breast cancer down Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting.
hsa-mir-206 cervical cancer down Decreased microRNA-206 and its function in cervical cancer.
hsa-mir-206 cervical cancer down miR-206 inhibits cell proliferation, migration, and invasion by targeting BAG3 in human cervical cancer.
hsa-mir-206 clear cell renal cell cancer down Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles.
hsa-mir-206 colorectal cancer down microRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer.
hsa-mir-206 colorectal cancer down MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2.
hsa-mir-206 colorectal cancer down miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer.
hsa-mir-206 colorectal cancer down MicroRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targeting TM4SF1.
hsa-mir-206 gastric cancer down MiR-206 inhibits gastric cancer proliferation in part by repressing CyclinD2.
hsa-mir-206 gastric cancer down Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
hsa-mir-206 gastric cancer down MicroRNA-206 suppresses gastric cancer cell growth and metastasis.
hsa-mir-206 gastric cancer down Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis.
hsa-mir-206 gastric cancer down Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.
hsa-mir-206 gastric cancer down MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway.
hsa-mir-206 glioblastoma down MicroRNA-206 Inhibited the Progression of Glioblastoma Through BCL-2.
hsa-mir-206 head and neck squamous cell carcinoma down Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
hsa-mir-206 head and neck squamous cell carcinoma down MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
hsa-mir-206 hepatocellular carcinoma down MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
hsa-mir-206 hepatocellular carcinoma down miR-206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9.
hsa-mir-206 hepatocellular carcinoma down MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
hsa-mir-206 hepatocellular carcinoma down LINC00707 contributes to hepatocellular carcinoma progression via sponging miR-206 to increase CDK14.
hsa-mir-206 laryngeal squamous cell carcinoma down miR-206 inhibits human laryngeal squamous cell carcinoma cell growth by regulation of cyclinD2.
hsa-mir-206 laryngeal squamous cell carcinoma down Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
hsa-mir-206 lung adenocarcinoma down MicroRNA-206 inhibits the viability and migration of human lung adenocarcinoma cells partly by targeting MET.
hsa-mir-206 lung adenocarcinoma down MicroRNA-206 suppresses TGF-? signalling to limit tumor growth and metastasis in lung adenocarcinoma.
hsa-mir-206 lung cancer down Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
hsa-mir-206 lung cancer down MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/ Akt/mTOR pathway.
hsa-mir-206 lung cancer down Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
hsa-mir-206 malignant melanoma down MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.
hsa-mir-206 medulloblastoma down MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.
hsa-mir-206 medulloblastoma down MicroRNA-206 inhibits the viability and migration of medulloblastoma cells by targeting LIM and SH3 protein 1.
hsa-mir-206 non-small cell lung cancer down miR-206 inhibits non small cell lung cancer cell proliferation and invasion by targeting SOX9.
hsa-mir-206 non-small cell lung cancer down MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3?/STAT3/HIF-1?/VEGF signaling.
hsa-mir-206 oral squamous cell carcinoma down MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma.
hsa-mir-206 oral squamous cell carcinoma down MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma [Retraction].
hsa-mir-206 osteosarcoma down MALAT1 induces osteosarcoma progression by targeting miR-206/CDK9 axis.
hsa-mir-206 ovarian cancer down [Role of miR-206/CDK4 in modulating the growth and chemotlerapy sensitivity of ovarian cancer cells].
hsa-mir-206 prostate cancer up MicroRNA-206 regulates the epithelial-mesenchymal transition and inhibits the invasion and metastasis of prostate cancer cells by targeting Annexin A2.
hsa-mir-206 prostate cancer down MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11.
hsa-mir-206 rhabdomyosarcoma down Heme oxygenase-1 controls an HDAC4-miR-206 pathway of oxidative stress in rhabdomyosarcoma.